Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence-Reference-Cited by-同舟云学术

Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence

Published:2014-01-03 Issue:3 Volume:14 Page:167-173
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Dézsi Csaba András

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s40256-013-0058-8/fulltext.html

Reference41 articles.

1. Ezzati M, Lopez AD, Rodgers A. Selected major risk factors and global and regional burden of disease. Lancet. 2002;360(9343):1347–60.

2. Kiss I. The Hungarian Society of Hypertension guideline for the management of arterial hypertension. Hypertonia Nephrol. 2009;13(82):81–168.

3. Mancia G, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens. 2013;31:1281–357.

4. National Institute for Health and Clinical Excellence (NICE) clinical guideline 127. Hypertension Clinical management of primary hypertension in adults. http://www.nice.org.uk/guidance/CG127/NICEGuidance .

5. Atlas SA. The renin–angiotensin–aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007;13(8) (Suppl S-b):S9–S20.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renin-Angiotensin-Aldosterone System Inhibitions and Cardiovascular Outcomes in Acute Myocardial Infarction With Renal Impairment;Mayo Clinic Proceedings;2023-09

2. Relationship between in-hospital angiotensin converting enzyme inhibitors and Angiotensin receptor blockers administration and delirium in the cardiac ICU;Hospital Practice;2023-07-07

3. Relationship between angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers prescribing and delirium in the ICU‐A secondary analysis;Journal of the American Geriatrics Society;2023-03-11

4. Mathematical modeling of antihypertensive therapy;Frontiers in Physiology;2022-12-14

5. Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019);eBioMedicine;2022-09